skip to the content

Clinical Trials

Hodgkin Disease Study

COG #AHOD0431:  A Phase III Study for the treatment of children and  adolescents with newly diagnosed low risk Hodgkin disease

Protocol ID

06.10.016T

Protocol Description

Hodgkin disease is one of the most treatable and curable childhood cancers. The standard treatment for Hodgkin disease involves chemotherapy and radiation therapy. Although subjects are cured of their cancer, some experience bad effects from treatment later in life. It is thought that if some subjects can be successfully treated with less intense therapy, those subjects might have less bad effects later in life. The goals of the study are:
• To find out if subjects who respond well to chemotherapy alone can be treated successfully without radiation therapy; and
• To see if subjects who relapse after chemotherapy alone can be treated successfully with less intensive treatment than standard relapse treatment.

Eligibility Criteria

Children and adolescents with Hodgkin disease

Primary Investigator(s)

  • Arlene Redner, MD

Contact Information

Christine Grabowski, CCRP
(718) 470-3401
grabowsk@lij.edu

Last Update

March 29, 2010
top
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Children's Health:
top
top